RESUMO
BACKGROUND: The immunologic features of nontuberculous mycobacterial pulmonary disease (NTM-PD) are largely unclear. This study investigated the immunologic features of NTM-PD using digital spatial profiling techniques. METHODS: Lung tissues obtained from six patients with NTM-PD between January 1, 2006, and December 31, 2020, at Seoul National University Hospital were subjected to RNA sequencing. Cores from the peribronchial areas were stained with CD3, CD68, and DNASyto13, and gene expression at the whole-transcriptome level was quantified using PCR amplification and Illumina sequencing. Lung tissues from six patients with bronchiectasis collected during the same period were used as controls. The RNA sequencing results were validated using immunohistochemistry (IHC) in another cohort (30 patients with NTM-PD and 15 patients with bronchiectasis). RESULTS: NTM-PD exhibited distinct gene expression patterns in T cells and macrophages. Gene set enrichment analysis revealed that pathways related to antigen presentation and processing were upregulated in NTM-PD, particularly in macrophages. Macrophages were more prevalent and the expression of genes associated with the M1 phenotype (CD40 and CD80) was significantly elevated. Although macrophages were activated in the NTM-PD group T cell activity was unaltered. Notably, expression of the costimulatory molecule CD28 was decreased in NTM-PD. IHC analysis showed that T cells expressing Foxp3 or TIM-3, which facilitate the regulatory functions of T cells, were increased. CONCLUSIONS: NTM-PD exhibits distinct immunologic signatures characterized by the activation of macrophages without T cell activation.
Assuntos
Infecções por Mycobacterium não Tuberculosas , Humanos , Masculino , Infecções por Mycobacterium não Tuberculosas/imunologia , Infecções por Mycobacterium não Tuberculosas/genética , Feminino , Pessoa de Meia-Idade , Idoso , Transcriptoma , Macrófagos/imunologia , Macrófagos/metabolismo , Pulmão/microbiologia , Pulmão/imunologia , Pulmão/patologia , Micobactérias não Tuberculosas/genética , Micobactérias não Tuberculosas/imunologia , Pneumopatias/genética , Pneumopatias/microbiologia , Pneumopatias/imunologia , Linfócitos T/imunologia , Perfilação da Expressão Gênica , Adulto , Bronquiectasia/imunologia , Bronquiectasia/genética , Bronquiectasia/microbiologiaRESUMO
Pseudomonas aeruginosa is a highly adaptable opportunistic pathogen capable of exploiting barriers and immune defects to cause chronic lung infections in conditions such as cystic fibrosis. In these contexts, host immune responses are ineffective at clearing persistent bacterial infection, instead driving a cycle of inflammatory lung damage. This review outlines key components of the host immune response to chronic P. aeruginosa infection within the lung, beginning with initial pathogen recognition, followed by a robust yet maladaptive innate immune response, and an ineffective adaptive immune response that propagates lung damage while permitting bacterial persistence. Untangling the interplay between host immunity and chronic P. aeruginosa infection will allow for the development and refinement of strategies to modulate immune-associated lung damage and potentiate the immune system to combat chronic infection more effectively.
Assuntos
Interações Hospedeiro-Patógeno , Imunidade Inata , Infecções por Pseudomonas , Pseudomonas aeruginosa , Humanos , Pseudomonas aeruginosa/imunologia , Infecções por Pseudomonas/imunologia , Infecções por Pseudomonas/microbiologia , Doença Crônica , Animais , Interações Hospedeiro-Patógeno/imunologia , Imunidade Adaptativa , Pneumopatias/imunologia , Pneumopatias/microbiologia , Fibrose Cística/imunologia , Fibrose Cística/microbiologia , Fibrose Cística/complicações , Pulmão/imunologia , Pulmão/microbiologiaRESUMO
Lactylation is a process where lactate, a cellular metabolism byproduct, is added to proteins, altering their functions. In the realm of macrophage activation, lactylation impacts inflammatory response and immune regulation. Understanding the effects of lactylation on macrophage activation is vital in lung diseases, as abnormal activation and function are pivotal in conditions like pneumonia, pulmonary fibrosis, COPD, and lung cancer. This review explores the concept of lactylation, its regulation of macrophage activation, and recent research progress in lung diseases. It offers new insights into lung disease pathogenesis and potential therapeutic targets.
Assuntos
Pneumopatias , Ativação de Macrófagos , Humanos , Ativação de Macrófagos/imunologia , Animais , Pneumopatias/imunologia , Pneumopatias/metabolismo , Ácido Láctico/metabolismo , Macrófagos/imunologia , Macrófagos/metabolismoRESUMO
BACKGROUND: IgG4-related disease (IgG4-RD) is an immune-mediated systemic inflammatory fibrotic disease, which is a relatively rare and novel disease that can involve multiple organs or tissues, with variable clinical manifestations, and for which pulmonary involvement has been reported relatively infrequently. METHODS: Here we report a case of pulmonary infection that was initially suspected and received anti-inflammatory treatment, but the symptoms did not improve. CT examination indicated progression of the pulmonary lesion, and the nature of the lesion could not be determined by tracheoscopy and bronchoalveolar lavage. The diagnosis of IgG4 related lung disease (IgG4-RLD) was confirmed by percutaneous lung biopsy. A joint literature analysis was conducted to improve clinicians' understanding of this disease. RESULTS: The patient's history, symptoms, signs and relevant examination results were analyzed. The final diagnosis was IgG4-RLD. CONCLUSIONS: When the clinical symptoms and imaging manifestations of the patients are consistent with IgG4-RLD, pathological examination can be appropriately performed to clarify the nature of the lesions. More consideration should be given to the possibility of disease diagnosis to avoid misdiagnosis and underdiagnosis, and proper treatment should be given at an early stage.
Assuntos
Doença Relacionada a Imunoglobulina G4 , Imunoglobulina G , Pneumopatias , Tomografia Computadorizada por Raios X , Humanos , Doença Relacionada a Imunoglobulina G4/diagnóstico , Doença Relacionada a Imunoglobulina G4/imunologia , Pneumopatias/diagnóstico , Pneumopatias/imunologia , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Masculino , Pulmão/diagnóstico por imagem , Pulmão/patologia , Pulmão/imunologia , Pessoa de Meia-Idade , BiópsiaRESUMO
PURPOSE OF REVIEW: The human commensal microbiota is now widely accepted as a key regulator of human health and disease. The composition of the mucosal associated microbiota has been shown to play a critical role in the lung health. The role of the mucosal microbiota in the development and severity of allergy, asthma, and occupational lung disease is only beginning to take shape. However, advances in our understanding of these links have tremendous potential to led to new clinical interventions to reduce allergy, asthma, and occupational lung disease morbidity. RECENT FINDINGS: We review recent work describing the relationship and role of the commensal microbiota in the development of allergy, asthma, and occupational lung disease. Our review primarily focuses on occupational exposures and the effects of the microbiome, both in composition and function. Data generated from these studies may lead to the development of interventions targeted at establishing and maintaining a healthy microbiota. We also highlight the role of environmental exposures and the effects on the commensal microbial community and their potential association with occupational lung disease. This review explores the current research describing the role of the human microbiome in the regulation of pulmonary health and disease, with a specific focus on the role of the mucosal microbiota in the development of allergy, asthma, and occupational lung disease.
Assuntos
Asma , Hipersensibilidade , Microbiota , Doenças Profissionais , Humanos , Microbiota/imunologia , Asma/imunologia , Asma/microbiologia , Hipersensibilidade/imunologia , Hipersensibilidade/microbiologia , Doenças Profissionais/microbiologia , Doenças Profissionais/imunologia , Exposição Ocupacional/efeitos adversos , Pneumopatias/microbiologia , Pneumopatias/imunologiaRESUMO
With the development of global social economy and the deepening of the aging population, diseases related to aging have received increasing attention. The pathogenesis of many respiratory diseases remains unclear, and lung aging is an independent risk factor for respiratory diseases. The aging mechanism of the lung may be involved in the occurrence and development of respiratory diseases. Aging-induced immune, oxidative stress, inflammation, and telomere changes can directly induce and promote the occurrence and development of lung aging. Meanwhile, the occurrence of lung aging also further aggravates the immune stress and inflammatory response of respiratory diseases; the two mutually affect each other and promote the development of respiratory diseases. Explaining the mechanism and treatment direction of these respiratory diseases from the perspective of lung aging will be a new idea and research field. This review summarizes the changes in pulmonary microenvironment, metabolic mechanisms, and the progression of respiratory diseases associated with aging.
Assuntos
Envelhecimento , Microambiente Celular , Pulmão , Estresse Oxidativo , Humanos , Envelhecimento/imunologia , Pulmão/imunologia , Animais , Pneumopatias/imunologia , Pneumopatias/etiologia , Inflamação/imunologiaRESUMO
Pulmonary manifestations of vasculitis are associated with significant morbidity and mortality in affected individuals. They result from a complex interplay between immune dysregulation, which leads to vascular inflammation and tissue damage. This review explored the underlying pathogenesis of pulmonary involvement in vasculitis, encompassing various forms such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and anti-GBM disease. Mechanisms involving ANCA and anti-GBM autoantibodies, neutrophil activation, and neutrophil extracellular trap (NETs) formation are discussed, along with the role of the complement system in inducing pulmonary injury. Furthermore, the impact of genetic predisposition and environmental factors on disease susceptibility and severity was considered, and the current treatment options were presented. Understanding the mechanisms involved in the pathogenesis of pulmonary vasculitis is crucial for developing targeted therapies and improving clinical outcomes in affected individuals.
Assuntos
Doença Antimembrana Basal Glomerular , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos , Humanos , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/imunologia , Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/patologia , Doença Antimembrana Basal Glomerular/imunologia , Doença Antimembrana Basal Glomerular/etiologia , Doença Antimembrana Basal Glomerular/patologia , Armadilhas Extracelulares/metabolismo , Armadilhas Extracelulares/imunologia , Anticorpos Anticitoplasma de Neutrófilos/imunologia , Pneumopatias/etiologia , Pneumopatias/imunologia , Pneumopatias/patologia , Pulmão/patologia , Pulmão/imunologia , Autoanticorpos/imunologia , Animais , Poliangiite Microscópica/imunologia , Poliangiite Microscópica/complicações , Poliangiite Microscópica/patologiaAssuntos
Doenças Autoimunes , Humanos , Doenças Autoimunes/imunologia , Doenças Autoimunes/etiologia , Animais , Pulmão/imunologia , Pulmão/patologia , Pneumopatias/imunologia , Pneumopatias/etiologia , Cardiopatias/imunologia , Cardiopatias/etiologia , Miocárdio/imunologia , Miocárdio/patologia , Miocárdio/metabolismoRESUMO
Programmed death-ligand 1 (PD-L1) is important in maintaining central and peripheral immune tolerance in normal tissues, mediating tumor immune escape and keeping the balance between anti- and pro-inflammatory responses. Inflammation plays an important role in inflammatory lung diseases. This article reviews the research progress and potential clinical value of PD-L1 in inflammatory lung diseases, including acute lung injury, chronic obstructive pulmonary disease, asthma and idiopathic pulmonary fibrosis.
Assuntos
Asma , Antígeno B7-H1 , Doença Pulmonar Obstrutiva Crônica , Humanos , Antígeno B7-H1/metabolismo , Antígeno B7-H1/imunologia , Doença Pulmonar Obstrutiva Crônica/imunologia , Asma/imunologia , Lesão Pulmonar Aguda/imunologia , Inflamação/imunologia , Fibrose Pulmonar Idiopática/imunologia , Fibrose Pulmonar Idiopática/metabolismo , Pneumopatias/imunologia , Pneumopatias/metabolismo , AnimaisRESUMO
Suppurative lung disease and wheezing are common respiratory diseases of childhood, however, due to poor understanding of underlying pathobiology, there are limited treatment options and disease recurrence is common. We aimed to profile the pulmonary and systemic immune response in children with wheeze and chronic suppurative lung disease for identification of endotypes that can inform improved clinical management. We used clinical microbiology data, highly multiplexed flow cytometry and immunoassays to compare pulmonary [bronchoalveolar lavage (BAL)] and systemic immunity in children with lung disease and controls. Unsupervised analytical approaches were applied to BAL immune data to explore biological endotypes. We identified two endotypes that were analogous in both frequency and immune signature across both respiratory diseases. The hyper-inflammatory endotype had a 12-fold increase in neutrophil infiltration and upregulation of 14 soluble signatures associated with type 2 inflammation and cell recruitment to tissue. The non-inflammatory endotype was not significantly different from controls. We showed these endotypes are measurable in a clinical setting and can be defined by measuring only three immune factors in BAL. We identified hyper-inflammatory and non-inflammatory endotypes common across pediatric wheeze and chronic suppurative lung disease that, if validated in future studies, have the potential to inform clinical management.
Assuntos
Líquido da Lavagem Broncoalveolar , Sons Respiratórios , Humanos , Sons Respiratórios/imunologia , Masculino , Feminino , Criança , Pré-Escolar , Líquido da Lavagem Broncoalveolar/imunologia , Pulmão/imunologia , Pulmão/patologia , Pneumopatias/imunologia , Pneumopatias/etiologia , Inflamação/imunologia , Lactente , Citocinas/metabolismo , Adolescente , BiomarcadoresRESUMO
The accumulation of senescent cells drives inflammaging and increases morbidity of chronic inflammatory lung diseases. Immune responses are built upon dynamic changes in cell metabolism that supply energy and substrates for cell proliferation, differentiation, and activation. Metabolic changes imposed by environmental stress and inflammation on immune cells and tissue microenvironment are thus chiefly involved in the pathophysiology of allergic and other immune-driven diseases. Altered cell metabolism is also a hallmark of cell senescence, a condition characterized by loss of proliferative activity in cells that remain metabolically active. Accelerated senescence can be triggered by acute or chronic stress and inflammatory responses. In contrast, replicative senescence occurs as part of the physiological aging process and has protective roles in cancer surveillance and wound healing. Importantly, cell senescence can also change or hamper response to diverse therapeutic treatments. Understanding the metabolic pathways of senescence in immune and structural cells is therefore critical to detect, prevent, or revert detrimental aspects of senescence-related immunopathology, by developing specific diagnostics and targeted therapies. In this paper, we review the main changes and metabolic alterations occurring in senescent immune cells (macrophages, B cells, T cells). Subsequently, we present the metabolic footprints described in translational studies in patients with chronic asthma and chronic obstructive pulmonary disease (COPD), and review the ongoing preclinical studies and clinical trials of therapeutic approaches aiming at targeting metabolic pathways to antagonize pathological senescence. Because this is a recently emerging field in allergy and clinical immunology, a better understanding of the metabolic profile of the complex landscape of cell senescence is needed. The progress achieved so far is already providing opportunities for new therapies, as well as for strategies aimed at disease prevention and supporting healthy aging.
Assuntos
Senescência Celular , Redes e Vias Metabólicas , Humanos , Senescência Celular/efeitos dos fármacos , Animais , Doença Crônica , Inflamação/metabolismo , Inflamação/imunologia , Pneumopatias/etiologia , Pneumopatias/tratamento farmacológico , Pneumopatias/metabolismo , Pneumopatias/imunologia , Doença Pulmonar Obstrutiva Crônica/metabolismo , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/imunologia , Envelhecimento/imunologia , Envelhecimento/metabolismoRESUMO
Abstract Sepsis induces a severe systemic inflammatory response that may result in multiple organ dysfunction and death. Studies using a protein derived from natural Hevea brasiliensis (rubber tree) latex, denominated Hev b 13, have demonstrated important anti-inflammatory effects, but no data have been published regarding its effects on sepsis. The aim of this study was to investigate the effects of Hev b 13 on the inflammatory response and lung lesions of septal rats. Male Wistar rats were submitted to cecal ligation and puncture (CLP), randomized into groups and treated with subcutaneously administered doses of 0.5/2.0/3.0 mg/Kg of Hev b 13. Next, animals were subdivided into three different points in time (1, 6 and 24 hours after treatments) for collection of blood samples and euthanasia accompanied by organ removal. Total and differential leukocyte counts, cytokine dosage and histological assessment were analyzed. Treatment with Hev b 13 resulted in a significant decline in total and differential leukocytes as well as suppression of TNF-α and IL-6 production, associated with the increase in IL-10 and IL-4 in plasma and lung tissue. Moreover, it reduced morphological and pathological changes found in the lungs, including neutrophil infiltration, edema and alveolar thickening. The present study concluded that Hev b 13 exerts anti-inflammatory effects and attenuates lung lesions in septal rats, showing potential for clinical application.
Resumo Sepse induz uma resposta inflamatória sistêmica grave podendo resultar em disfunção de múltiplos órgãos e morte. Pesquisas utilizando uma proteína derivada do látex natural de Hevea brasiliensis (seringueira), denominada Hev b 13 tem demonstrado importantes efeitos anti-inflamatórios, mas nenhum dado foi publicado dos seus efeitos na sepse. O objetivo deste estudo foi investigar os efeitos da Hev b 13 na resposta inflamatória e na lesão pulmonar de ratos com sepse. Ratos machos da linhagem Wistar foram submetidos a ligação e perfuração do ceco (LPC), randomizados em grupos e tratados com as doses 0,5/2,0/3,0 mg/Kg de Hev b 13 subcutâneo. Após subdividiu-se os animais em três pontos diferentes de tempo (1, 6 e 24 horas após os tratamentos) para coleta de amostras sanguíneas e eutanásia com remoção dos órgãos. Contagem total e diferencial de leucócitos, dosagem de citocinas e avaliação histológica foram analisadas. O tratamento com a Hev b 13 resultou em diminuição significativa de leucócitos totais e diferenciais bem como suprimiu a produção de TNF-α e IL-6, associado ao aumento de IL-10 e IL-4 no plasma e tecido pulmonar. Além disso, reduziu as alterações morfológicas e patológicas encontradas nos pulmões, incluindo infiltrado de neutrófilos, edema e espessamento alveolar. Este estudo concluiu que a Hev b 13 tem efeitos anti-inflamatórios e atenua lesões pulmonares em ratos com sepse, apresentando potencialidades para aplicabilidade clínica.
Assuntos
Animais , Masculino , Ratos , Proteínas de Plantas/farmacologia , Antígenos de Plantas/farmacologia , Pulmão/efeitos dos fármacos , Pulmão/imunologia , Pulmão/metabolismo , Pneumopatias/metabolismo , Proteínas de Plantas/administração & dosagem , Distribuição Aleatória , Citocinas/imunologia , Citocinas/metabolismo , Citocinas/sangue , Ratos Wistar , Sepse/metabolismo , Modelos Animais de Doenças , Antígenos de Plantas/administração & dosagem , Pneumopatias/imunologiaRESUMO
OBJECTIVE: To analyze the prevalence of myositis-specific and myositis-associated autoantibodies and their clinical correlations in a large series of patients with dermatomyositis/polymyositis. METHOD: This cross-sectional study enrolled 127 dermatomyositis cases and 95 polymyositis cases. The disease-related autoantibody profiles were determined using a commercially available blood testing kit. RESULTS: The prevalence of myositis-specific autoantibodies in all 222 patients was 34.4%, whereas myositis-associated autoantibodies were found in 41.4% of the patients. The most frequently found autoantibody was anti-Ro-52 (36.9%), followed by anti-Jo-1 (18.9%), anti-Mi-2 (8.1%), anti-Ku (4.1%), anti-SRP (3.2%), anti-PL-7 (3.2%), anti-PL-12 (2.7%), anti-PM/Scl75 (2.7%), and anti-PM/Scl100 (2.7%). The distributions of these autoantibodies were comparable between polymyositis and dermatomyositis, except for a higher prevalence of anti-Jo-1 in polymyositis. Anti-Mi-2 was more prevalent in dermatomyositis. Notably, in the multivariate analysis, anti-Mi-2 and anti-Ro-52 were associated with photosensitivity and pulmonary disorders, respectively, in dermatomyositis. Anti-Jo-1 was significantly correlated with pulmonary disorders in polymyositis. Moreover, anti-Ro-52 was associated with anti-Jo-1 in both diseases. No significant correlation was observed between the remaining autoantibodies and the clinical and/or laboratory findings. CONCLUSIONS: Our data are consistent with those from other published studies involving other populations, although certain findings warrant consideration. Anti-Ro-52 and anti-Jo-1 were strongly associated with one another. Anti-Ro-52 was correlated with pulmonary disorders in dermatomyositis, whereas anti-Jo-1 was correlated with pulmonary alterations in polymyositis. .
Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Autoanticorpos/sangue , Miosite/imunologia , Idade de Início , Estudos Transversais , Dermatomiosite/sangue , Dermatomiosite/imunologia , Modelos Logísticos , Pneumopatias/sangue , Pneumopatias/imunologia , Força Muscular , Miosite/sangue , Ribonucleoproteínas/sangue , Estatísticas não Paramétricas , Fatores de TempoRESUMO
Respiratory diseases are frequent complications in HIV infection. High Resolution Computed Tomography (HRCT) has proven superior to conventional imaging techniques to establish a pulmonary disease diagnosis. A study was conducted in order to establish the association between tomographic pulmonary patterns and immune status of HIV-infected patients. We evaluated 35 patients with respiratory symptoms and / or abnormal chest radiograph. An association was observed between the presence of ground glass pattern and P jirovecii infection. Likewise, a correlation between pulmonary histoplasmosis diagnosis and honeycomb pattern, lung cysts and nodules was established. Few correlation between tomographic patterns and CD4 + T lymphocyte counts was observed. In summary, HRCT findings can predict certain types of infection; nevertheless, further studies are required to extrapolate this association to other noninfectious lung diseases in HIV-infected patients.
Las enfermedades respiratorias constituyen complicaciones frecuentes en la infección por VIH. La Tomografía Axial Computarizada de Alta Resolución (TACAR) ha demostrado ser superior a las técnicas de imagen convencionales para establecer diagnóstico de enfermedad pulmonar. Se realizó un estudio con la finalidad de establecer la asociación entre patrones tomográficos pulmonares y el estado inmunológico de pacientes VIH+. Se evaluaron 35 pacientes sintomáticos respiratorios y/o con radiografía torácica patológica. Se observó una asociación entre la presencia de patrón en vidrio esmerilado e infección por P jirovecii. Asimismo, se observó una asociación entre diagnóstico de histoplasmosis pulmonar y patrón de panal de abejas, quistes pulmonares y nódulos. Se demostraron pocas correlaciones entre patrones tomográficos y conteo de linfocitos T CD4+. En conclusión, los hallazgos en la TACAR pueden predecir determinados tipos de infección requiriendo de más estudios para extrapolar esta asociación a otras enfermedades pulmonares no infecciosas en el paciente VIH+.
Assuntos
Humanos , Masculino , Adulto , Feminino , Pessoa de Meia-Idade , Pneumopatias , Infecções por HIV , Infecções por HIV/sangue , Aumento da Imagem , Pneumopatias/imunologia , Pneumopatias/virologia , Infecções por HIV/imunologia , Infecções por HIV/tratamento farmacológico , Terapia Antirretroviral de Alta Atividade , Tomografia Computadorizada por Raios XRESUMO
La presencia de nódulos pulmonares cavitados nos obliga a plantear varios diagnósticos diferenciales. El diagnóstico definitivo hay que definirlo en base a lo que nos aportan los exámenes serológicos, imagenológicos e histológicos, y correlacionar con la forma de presentación clínica. Un diagnóstico importante que debe ser considerado es la Granulomatosis de Wegener (GW) que corresponde a una vasculitis, en la mayoría de los casos sistémica y en la que encontramos anticuerpos anticitoplasma de neutrófilos de histología compatible con vasculitis. Las patologías infecciosas son otra causa importante de lesiones nodulares en pulmón. Si estamos ante pacientes con algún grado de inmunosupresión, no debemos olvidar la etiología micótica y dentro de esta la infección causada por hongos del grupo Zigomicetes (mucormicosis), sobre todo por la urgencia de realizar tratamiento agresivo y su alta mortalidad.
The presence of cavitated pulmonary nodules obliges one to pose various differential diagnoses. A definite diagnosis must be defined based on serological, imagenological and histological exams, and contrast these with the clinical manifestation. An important diagnosis that must be considered is Wegeners granulomatosis, which corresponds to a Vasculitis, usually systemic, in which we find antineutrophil cytoplasmic antibodies and histology compatible with Vasculitis. Infectious pathologies are an important cause of pulmonary nodular lesions. If faced with a patient with a degree of immunosuppression, we must not forget the mycotic etiology, and within this the infection caused by fungi from the Zygomycetes group (mucomycosis), above all due to the urgency of aggressive treatment and its high mortality rate.
Assuntos
Humanos , Feminino , Idoso , Anticorpos Anticitoplasma de Neutrófilos/imunologia , Pneumopatias/imunologia , Pneumopatias/microbiologia , Mucormicose/complicações , Vasculite/imunologia , Vasculite/microbiologia , Granulomatose com Poliangiite , Zigomicose/complicaçõesRESUMO
La enfermedad antimembrana basal glomerular (anti-MBG) es una condición que se manifiesta clínicamente como glomerulonefritis rápidamente progresiva y hemorragia alveolar, también llamada Síndrome Riñón- Pulmón. Se asocia a la presencia de autoanticuerpos dirigidos contra el colágeno tipo IV de la membrana basal glomerular. Las vasculitis sistémicas asociadas a ANCA también pueden manifestarse como Síndrome Riñón-Pulmón, cuadro clínico a veces indistinguible de la enfermedad anti-MBG. La concomitancia de ANCA y anticuerpos anti-MBG en el Síndrome Riñón-Pulmón es del orden de un 30 por ciento, según distintos reportes de la literatura. El perfil clínico, el pronóstico y el rol fisiopatológico de cada anticuerpo en este grupo de pacientes todavía son materia de investigación. El mecanismo patogénico inicial parece ser el daño mediado por ANCA, que puede inducir la aparición de anticuerpos anti-MBG, los que perpetúan el daño en el glomérulo.
Anti-glomerular basement membrane (anti-MBG) disease is a condition that is manifested clinically as rapidly progressive glomerulonephritis and alveolar hemorrhage, also known as Pulmonary-Renal Syndrome. It is associated with the presence of autoantibodies directed against type IV collagen of the glomerular basement membrane. Systemic vasculitis associated with ANCA may also manifest as Pulmonary-Renal Syndrome, sometimes clinically indistinguishable from the anti-MBG disease.The concomitance of ANCA and anti-MBG antibodies in the Pulmonary-Renal Syndrome is about 30 percent, according to various reports in literature. The clinical profile, prognosis and physiopathologic roles of each antibody in this group of patients is still under investigation. The pathogenic mechanism appears to be the initial damage mediated by ANCA, which may induce the appearance of anti-MBG, those who perpetuate the glomerulus damage.
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Doença Antimembrana Basal Glomerular/complicações , Doença Antimembrana Basal Glomerular/imunologia , Pneumopatias/complicações , Pneumopatias/imunologia , Nefropatias/complicações , Nefropatias/imunologia , Anticorpos Anticitoplasma de Neutrófilos , Glomérulos Renais/imunologia , Glomérulos Renais/patologia , Pulmão/imunologia , Pulmão/patologia , SíndromeRESUMO
Introducción: A lo largo de tres décadas el interés por los macrólidos se ha incrementado considerablemente. Objetivo: Realizar una actualización en torno a los mecanismos inmunomoduladores de estas drogas sobre la cascada inflamatoria, la función del neutrófilo, el broncoespasmo y el biofilm de la Pseudomona aeruginosa. Material y Métodos: Se realizó una búsqueda bibliográfica considerando revisiones o artículos originales indexados en el National Library of Medicine (MEDLINE/Pubmed) empleando las palabras: macrolides, azithromycin, clarithromycin, immunomodulating, antiinflammatory, airway, cystic fibrosis, asthma sinusitis y children. Resultados: Las dosis bajas de macrólidos han producido un incremento dramático en la sobrevida de pacientes con panbronquiolitis difusa. Existe un desarrollo de investigaciones en otras enfermedades pulmonares crónicas con un componente inflamatorio como asma, fibrosis quística y bronquiectasias. No existe evidencia que guíe el correcto uso de estas drogas, sino más bien recomendaciones de ensayo. Conclusiones: Existen beneficios y posibles efectos adversos reconocidos que deben ser determinados de forma clara antes de ser indicados en otras condiciones pulmonares.